Publications
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Central Library of Charles University
- Case reports of patients with ALK-positive NSCLC and brain metastases2023 | First Faculty of Medicine
- Přínos sekvenování nové generace v terapii nemalobuněčného plicního karcinomu - zaměřeno na rezistence u EGFR mutovaného nemalobuněčného plicního karcinomu2023 | First Faculty of Medicine
- Treatment of lung cancer with targetable mutations - new drugs and indications2023 | First Faculty of Medicine
- Targeted treatment and immunotherapy of advanced non-small cell lung cancer2022 | First Faculty of Medicine
- Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Malignant pleural mesothelioma – case report2023 | First Faculty of Medicine
- Osimertinib in treating advanced non-squamous non-small cell lung cancer2022 | First Faculty of Medicine
- Imunoterapie u pacientky s malobuněčným plicním karcinomem2022 | First Faculty of Medicine
- Primární nádory pleury2022 | First Faculty of Medicine
Loading network view...